TIAA CREF INVESTMENT MANAGEMENT LLC - INOTEK PHARMACEUTICALS CORP ownership

INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 86 filers reported holding INOTEK PHARMACEUTICALS CORP in Q4 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of INOTEK PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2017$112,000
-67.2%
55,9230.0%0.00%
Q4 2016$341,000
-29.3%
55,923
+10.1%
0.00%
Q3 2016$482,000
+27.5%
50,7920.0%0.00%
Q2 2016$378,00050,7920.00%
Other shareholders

There were no reported owners of INOTEK PHARMACEUTICALS CORP in Q4 2016.

NameSharesValueWeighting ↓
View complete list of INOTEK PHARMACEUTICALS CORP shareholders